How to appeal a Humana hospice / palliative — eligibility, gip, recertification, concurrent care denial

The framework that applies to your appeal

Medicare Advantage plans follow a separate appeal track from commercial plans. Reconsideration must be requested within 60 days; if the plan misses its deadline, the case auto-forwards to the IRE (Maximus).

Humana-specific note: Heavily Medicare Advantage focused. MA-specific appeal track (42 CFR Part 422 Subpart M) applies — 60 days to request reconsideration, NOT the 180 days for commercial plans. Auto-forward to IRE (Maximus) if Humana misses deadline.

What Humana's policy requires for hospice / palliative — eligibility, gip, recertification, concurrent care

Cited policy: Humana Medicare Advantage Hospice — for CY2025+ MA hospice has returned to Original Medicare carve-out per CMMI VBID expiration; recertification follows CMS 42 CFR §418.21 + §418.22 + applicable MAC LCD

Subsequent benefit period certification by hospice physician (single physician, not two); F2F encounter by hospice physician or NP within 30 days prior to start of 3rd and subsequent benefit periods; documented continued decline supporting <=6 mo prognosis; serial prognostic indicators per LCD.

How Humana denies hospice / palliative — eligibility, gip, recertification, concurrent care — and how to counter it

Where Humana pushes back: 1) 'Patient stabilized — no longer eligible'; 2) 'F2F encounter documentation incomplete'; 3) 'Decline criteria not met for this benefit period'; 4) 'Long length of stay suggests inappropriate eligibility'.

Counter-arguments that hold up: Cite 42 CFR §418.21 (benefit periods) and §418.22(b)(3) (F2F requirement). Submit F2F note by hospice MD/NP within 30-day window with narrative of decline. Submit serial PPS / FAST / weight / albumin data showing continued decline (small declines count — disease runs normal course standard). Cite applicable MAC LCD (Palmetto L34538 / NGS L33393 / etc.) and quote per-diagnosis criteria. Long LOS is not disqualifying — CMS Hospice Quality Reporting Program data show wide variation in LOS by diagnosis (dementia and stroke often >180 days). Cite CMS-4201-F if MA plan applying more restrictive criteria than Original Medicare.

What Humana typically denies for hospice / palliative — eligibility, gip, recertification, concurrent care

Across Humana's commercial and Medicare books, denials cluster around a small number of patterns. For hospice / palliative — eligibility, gip, recertification, concurrent care, expect:

• MA plan step therapy on Part B drugs
• Skilled nursing facility days
• Prior auth on specialty drugs
• OON emergency reduction

Treatments most often denied in this category

These are the hospice / palliative — eligibility, gip, recertification, concurrent care treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Hospice eligibility
• Hospice recertification
• Hospice GIP
• Hospice CHC
• Hospice respite
• Hospice routine

How to submit the appeal to Humana

1. Read the denial letter — note the exact denial reason code and the appeal deadline (60 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Humana cited in the denial.
3. File the appeal through Humana's portal (members: https://www.humana.com ; providers: https://www.humana.com/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In KY, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Humana's prior-authorization criteria by drug: Humana PA criteria on ApprovalHelp.